Bioequivalence Study to Compare Diclofenac Potassium Coated Tablet (50 mg Diclofenac Potassium) Versus Cataflam ® 50 Coated Tablet (50 mg Diclofenac Potassium), in Healthy Subjects Under Fasting Condition
Conditions:   Non-steroidal Anti-inflammatory (NSAID);   Analgesic;   Antipyretic Interventions:   Drug: Diclofenac Potassium coated tablet (50 mg Diclofenac Potassium);   Drug: Cataflam® 50 coated tablet Sponsor:   Pharmactive Ilac Sanayi ve Tic A.S. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2021 Category: Research Source Type: clinical trials

Acupuncture as adjunctive therapy for acute renal colic caused by urinary calculi: study protocol for a randomized controlled trial
DiscussionThe finding of this trial will provide evidence on the efficacy and safety of acupuncture for the treatment of ARCUC. The results of this study will be published in peer-reviewed journals.Trial registrationClinicalTrials.gov ChiCTR1900025202. Registered on August 16, 2019. (Source: Trials)
Source: Trials - September 25, 2021 Category: Research Source Type: clinical trials